S&P 500 Futures
(0.02%) 5 309.25 points
Dow J Futures
(0.05%) 40 165 points
Nasdaq Futures
(0.04%) 18 512 points
Oil
(1.68%) $82.72
Gas
(0.12%) $1.720
Gold
(0.80%) $2 230.50
Silver
(-0.22%) $24.70
Platinum
(0.38%) $913.15
USD/EUR
(0.33%) $0.926
USD/NOK
(0.57%) $10.83
USD/GBP
(0.10%) $0.792
USD/RUB
(-0.08%) $92.36

Realtime updates for Sequana Medical NV [SEQUA.BR]

Exchange: EURONEXT Industry: Medical Devices
Last Updated28 Mar 2024 @ 08:08

-5.13% 1.480

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 08:08):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure...

Stats
Today's Volume 301 687
Average Volume 90 759.00
Market Cap 46.48M
EPS €0 ( 2023-02-09 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -1.120
ATR14 €0.0170 (1.15%)

Volume Correlation

Long: 0.00 (neutral)
Short: -0.90 (very strong negative)
Signal:(57.644) Neutral

Sequana Medical NV Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sequana Medical NV Correlation - Currency/Commodity

The country flag 0.47
( neutral )
The country flag 0.19
( neutral )
The country flag 0.00
( neutral )
The country flag -0.01
( neutral )
The country flag 0.00
( neutral )
The country flag -0.77
( moderate negative )

Sequana Medical NV Financials

Annual 2022
Revenue: €922 687
Gross Profit: €718 090 (77.83 %)
EPS: €-1.350
Q2 2023
Revenue: €384 173
Gross Profit: €-1.94M (-505.82 %)
EPS: €-0.650
Q1 2023
Revenue: €192 087
Gross Profit: €147 851 (76.97 %)
EPS: €-0.330
Q4 2022
Revenue: €458 241
Gross Profit: €-2.45M (-534.16 %)
EPS: €-0.670

Financial Reports:

No articles found.

Sequana Medical NV

Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators